VMY-2-109

N/A

Report date: 2022/02/08 17:53:01
NME

Base Information

Drug NameVMY-2-109
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor; alpha3/beta4 antagonistsNeuronal acetylcholine receptor; alpha4/beta2 antagonists
TargetsNeuronal acetylcholine receptor alpha4/beta2 complexNeuronal acetylcholine receptor; alpha3/beta4
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDuke UniversityGeorgetown University (The)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke UniversityGeorgetown University (The)
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A